imdevimab   Click here for help

GtoPdb Ligand ID: 11328

Synonyms: REGN-10987 | REGN10987 | Ronapreve® (imdevimab + casirivimab)
Approved drug
imdevimab is an approved drug (Japan, EMA and UK MHRA (2021))
Compound class: Antibody
Comment: Imdevimab is a fully human monoclonal antibody against the surface spike protein of SARS-CoV-2 [1-2]. It is a virus neutralising mAb that was developed by Regeneron.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
Classification Click here for help
Compound class Antibody
Approved drug? Yes. Japan (2021)  |  UK MHRA (2021)  |  EMA (2021)
International Nonproprietary Names Click here for help
INN number INN
11863 imdevimab
Synonyms Click here for help
REGN-10987 | REGN10987 | Ronapreve® (imdevimab + casirivimab)
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 1108
Other databases
GtoPdb PubChem SID 434321763
Search PubMed clinical trials imdevimab
Search PubMed titles imdevimab
Search PubMed titles/abstracts imdevimab